Kamen Brain Tumor Foundation

Analysis

Kamen Brain Tumor Foundation is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in August 2016, 10 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Kamen Brain Tumor Foundation reported income of $557k and spending of $591k, spending 106% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $104k to $557k (+433%), an average of +52% a year. The sharpest change came in the year to December 2022, when income rose by 432%. Over the whole period it spent 120% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Kamen Brain Tumor Foundation sits at the 56th percentile: it is larger than about 56% of them. Against every charity in United States with reported income it ranks in the 72nd percentile, and in the 68th percentile within NY. Charities of a similar size with the same main cause include Beginnings for Parents of Children Who Are Deaf or Hard of Hearing-Sc ($557k), New York City Hemophilia Chapter ($557k) and Mobility Matters ($557k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 100% of the total. At year end it held assets of $157k against liabilities of $0, net assets of $157k.

Data notes from the register: Spending has exceeded income in each of the last three reported years, so the charity has been drawing on reserves or other funds.